Editorial standards · Long Island
Medical & Public Health Sources
We prioritize government health agencies and primary public-health resources. Links below provide further reading and verification.
Treatment and provider information
- FindTreatment.gov treatment locator (SAMHSA)
- Find addiction treatment in New York State (NY OASAS)
- OASAS treatment provider directory (NY OASAS)
- National Helpline (SAMHSA)
Withdrawal and treatment science
- Treatment and recovery (NIDA)
- Information about medications for opioid use disorder (FDA)
- About overdose prevention (CDC)
- Alcohol Treatment Navigator (NIAAA)
- About The ASAM Criteria (levels of care) (American Society of Addiction Medicine)
- Alcohol withdrawal (MedlinePlus, U.S. National Library of Medicine)
- Opiate and opioid withdrawal (MedlinePlus, U.S. National Library of Medicine)
Crisis and support
- NYS HOPEline: 24/7 help and referral (NY OASAS)
- Free help with health insurance questions in New York (Community Health Advocates)
- Support for families and friends of people who drink (Al-Anon)
- Support for families affected by drug use (Nar-Anon)
- Find an A.A. meeting (Alcoholics Anonymous)
Published through ISSUP
Professional education articles on 7-hydroxymitragynine (7-OH) and kratom published through the International Society of Substance Use Professionals. Citation does not imply ISSUP endorsement of this site.
- What Is 7-OH? The Emerging Opioid Threat Addiction Professionals Need to Understand in 2026. An overview of 7-hydroxymitragynine, its opioid-like effects, and public health concerns.
- 7-OH Withdrawal: Symptoms, Timeline, and Treatment. Withdrawal symptoms, typical timelines, and treatment planning considerations.
- The Dangers of 7-OH and Why Accessibility in New York Raises Concerns. Public health discussion of 7-OH product availability in New York.
- 7-Hydroxymitragynine (7-OH) and Kratom Withdrawal. Kratom dependence, 7-OH exposure, and overlapping withdrawal concerns.
Editorial limits
Sources support general education, not an individualized recommendation. Medical content should receive human review before publication and should be discussed with a qualified professional.